Home > Boards > US Listed > Biotechs > Cytokinetics, Inc. (CYTK)

Top line results will likely be released in November.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
H2R Member Profile
 
Followed By 20
Posts 1,688
Boards Moderated 0
Alias Born 07/17/14
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 5:18:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/7/2020 4:40:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2020 4:00:55 PM
Cytokinetics Reports Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/6/2020 4:00:10 PM
Cytokinetics to Announce Second Quarter Results on August 6, 2020 GlobeNewswire Inc. - 7/23/2020 4:00:10 PM
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Ad... GlobeNewswire Inc. - 7/21/2020 4:00:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/17/2020 5:16:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/17/2020 5:15:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/17/2020 8:18:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/17/2020 7:46:34 AM
Cytokinetics Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc. - 7/16/2020 11:32:12 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/15/2020 5:26:00 PM
Cytokinetics Announces Proposed Public Offering of Common Stock GlobeNewswire Inc. - 7/15/2020 4:00:10 PM
Cytokinetics Provides Updates on Its Cardiovascular Pipeline and Strategies to Build a Commercial Franchise at Today’s Virt... GlobeNewswire Inc. - 7/15/2020 7:30:10 AM
Cytokinetics Announces Licensing Collaboration and Royalty Monetization Deals with RTW Investments Focused to CK-3773274, Nex... GlobeNewswire Inc. - 7/14/2020 7:30:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/13/2020 5:34:36 PM
Cytokinetics Announces Participation in the Launch of Kainomyx, Inc. Focused to the Treatment of Parasitic Diseases GlobeNewswire Inc. - 7/13/2020 7:30:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/9/2020 5:37:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/8/2020 5:09:34 PM
Cytokinetics to Host Virtual Investor & Analyst Day on July 15, 2020 GlobeNewswire Inc. - 7/1/2020 4:00:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/23/2020 5:00:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/22/2020 5:44:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2020 6:08:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 5:58:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 6:32:46 PM
H2R   Friday, 09/29/17 02:13:15 PM
Re: H2R post# 1440
Post # of 1493 
Top line results will likely be released in November.

Cytokinetics The results of the phase 3 trial of tirasemtiv in ALS will be presented at a conference on December 8, 2017.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist